HighVista Strategies’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,519
| Closed | -$512K | – | 156 |
|
|
2024
Q1 | $512K | Buy |
+21,519
| New | +$512K | 0.18% | 117 |
|
|
2023
Q4 | – | Sell |
-29,490
| Closed | -$428K | – | 144 |
|
|
2023
Q3 | $428K | Sell |
29,490
-4,086
| -12% | -$59.3K | 0.2% | 122 |
|
|
2023
Q2 | $703K | Buy |
33,576
+7,972
| +31% | +$167K | 0.32% | 87 |
|
|
2023
Q1 | $541K | Buy |
25,604
+6,943
| +37% | +$147K | 0.44% | 71 |
|
|
2022
Q4 | $475K | Sell |
18,661
-18,443
| -50% | -$469K | 0.28% | 76 |
|
|
2022
Q3 | $892K | Buy |
+37,104
| New | +$892K | 0.51% | 46 |
|
|
2022
Q1 | – | Sell |
-38,347
| Closed | -$839K | – | 97 |
|
|
2021
Q4 | $839K | Sell |
38,347
-7,237
| -16% | -$158K | 0.67% | 55 |
|
|
2021
Q3 | $872K | Sell |
45,584
-2,230
| -5% | -$42.7K | 0.58% | 58 |
|
|
2021
Q2 | $821K | Buy |
47,814
+12,941
| +37% | +$222K | 0.58% | 37 |
|
|
2021
Q1 | $779K | Buy |
+34,873
| New | +$779K | 0.58% | 31 |
|